Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
- Conditions
- Nursing Home ResidentSkilled Nursing FacilityDepressionFeasibility StudiesCaregiver
- Registration Number
- NCT07220486
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL) for skilled nursing facility residents and their primary support person. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. The researchers will compare the InSTILL program to minimally enhanced usual care. Participants will be randomly assigned to receive either the InSTILL program or minimally enhanced usual care. Participants will complete assessments at three timepoints (all) and a brief-exit interview.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Patient and care partner both aged ≥ 18 years
- Patient with care partner (known person providing regular health-related, socioemotional, or practical support) willing to participate
- Patient reporting depression symptoms on a screening tool (Patient Health Questionnaire)
- Patient intended length of nursing facility stay < 7 days
- Patient evidencing more than mild impairment on a cognitive screen (Brief Interview for Mental Status)
- Patient's roommate in skilled nursing facility already enrolled in study/intervention
- Either patient or care partner reporting high risk of suicidality, based on a standardized safety assessment tool
- Either patient or care partner participating in newly initiated psychotherapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Treatment Credibility peri-intervention 3-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 30) scores indicate greater credibility.
Client Satisfaction Questionnaire immediately after the intervention 3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.
Feasibility of Recruitment baseline, pre-intervention Percentage of eligible approached dyads that are enrolled into the study.
Feasibility of Data Collection 1 month follow-up Percentage of all participants with no measure fully missing at follow-up.
Treatment Adherence immediately after the intervention Percentage of InSTILL participants completing 5/8 sessions
Clinician Fidelity immediately after the intervention Percentage of InSTILL sessions delivered with 100% adherence on a study-specific Fidelity Checklist.
Adverse Events 1 month follow-up Any adverse events related to participation in the study.
Treatment Acceptability Survey immediately after the intervention Percentage of InSTILL participants scoring above the scale midpoint on all 9 Treatment Acceptability Survey items (developed for the current study).
- Secondary Outcome Measures
Name Time Method PHQ-9 baseline, pre-intervention; immediately after the intervention; 1 month follow-up 9-item self-report measure of depression symptoms. Higher scores (min=0, max=27) indicate greater depressive symptoms.
Selection, Optimization, and Compensation in Everyday Use baseline, pre-intervention; immediately after the intervention; 1 month follow-up 4-item self-report measure of the application of selection, optimization, and compensation strategies in daily life.
Committed Action Questionnaire baseline, pre-intervention; immediately after the intervention; 1 month follow-up 8-item self-report measure of pursuit of valued goals despite challenges and difficulties
Perceptions of Collaboration Questionnaire baseline, pre-intervention; immediately after the intervention; 1 month follow-up 12-item self-report measure of dyadic coping, including collaboration and interpersonal enjoyment.
General Anxiety Disorder-7 baseline, pre-intervention; immediately after the intervention; 1 month follow-up 7-item self-report measure of anxiety symptoms.
Euro QoL-5D 5L baseline, pre-intervention; immediately after the intervention; 1 month follow-up 6-item self-report measure of subjective health-related quality of life.
Relationship Assessment Scale baseline, pre-intervention; immediately after the intervention; 1 month follow-up Single-item self-report measure of relationship satisfaction with study partner.
Preparedness for Future Care baseline, pre-intervention; immediately after the intervention; 1 month follow-up 5-item self-report measure of active preparation for future health care needs.
COREQ immediately after the intervention 4-item self-report of nursing facility satisfaction.
University of Washington Resilience Scale Short Form baseline, pre-intervention; immediately after the intervention; 1 month follow-up 4-item self-report of an individual's perceived resilience.
Zarit Burden Interview baseline, pre-intervention; immediately after the intervention; 1 month follow-up 4-item self-report screener of caregiver burden. Administered to care partners only.
Psychotropic medication use baseline, pre-intervention; immediately after the intervention; 1 month follow-up Chart or self reported psychotropic medication use
Re-hospitalization immediately after the intervention; 1 month follow-up Resident re-hospitalization during the study period
